Clinical trial Recruiting at 1 site Interventional Ages 18 and up

Integrated healthcare for frail patients with heart failure

Official title: INTEgRated Health CARE for Patients With Frailty and Heart Failure (INTERCARE-HF): Evaluation of an Innovation Project

Run by Vestre Viken Hospital Trust · NCT06444321 · Data updated 2026-11-12

This study tests whether a new team-based healthcare approach can help frail heart failure patients manage their symptoms better and improve their quality of life.

More Heart Failure trials

Quick facts

Study typeInterventional
Ages18 Years and up
SexAll
Enrollment60 (estimated)
SponsorVestre Viken Hospital Trust
Academic / other
Locations1 site (Drammen, Akershus)
StatusRecruiting
StartedJune 6, 2024
Main results expectedJune 1, 2025
Study endsDecember 20, 2028
Registry record updatedJune 13, 2024
Trial IDNCT06444321 on ClinicalTrials.gov

Is this trial a fit for you?

Likely a good fit

Ideal candidates include adults over 18 years old who are hospitalized with heart failure symptoms and have a Clinical Frailty Score of 5 or higher.

Probably not a fit

Patients with major co-morbidities, psychosocial issues, or those unable to understand Norwegian may not benefit from this study.

A plain-English reading of the study's rules. Only the study team can confirm whether you qualify.

What this trial studies

This study evaluates the impact of integrated healthcare services on heart failure patients who are severely frail. It aims to establish interdisciplinary teams that will assess individual patient needs, conduct advance care planning, and develop tailored treatment plans. By focusing on coordinated follow-up across healthcare boundaries, the study seeks to improve symptom management and quality of life for this vulnerable population. The approach addresses a significant gap in current cardiovascular interventions, which often exclude frail patients.

Why it matters

Potential benefit: If successful, this study could significantly enhance the quality of life and health outcomes for frail elderly patients suffering from heart failure.

How similar studies have gone: While integrated care approaches for frail patients are gaining attention, this specific study represents a novel effort to directly address the intersection of frailty and heart failure.

Who can join: the full rules

Show full inclusion / exclusion criteria
Inclusion Criteria:

* Age \>18 years old
* Admitted to hospital with heart failure with symptoms of decompensation including dyspnoea in NYHA class ≥ II, pulmonary congestion on chest x-ray and/or other signs like oedema or positive rales on auscultation and elevated NT-proBNP concentrations at screening
* Clinical Frailty Score ≥5
* Signed informed consent by patient and closest relatives\* and expected cooperation according to the protocol, ICH/GCP and national/local regulations

  * Although we preferably will recruit both patients and their relatives, participation from the next-of-kin will not be an exclusion criterium.

Exclusion Criteria:

* Inability to comply with all study requirements, due to major co-morbidities or psychosocial issues, or a history of noncompliance, that might compromise the patient's ability to understand and/or comply with the protocol instructions or follow-up procedures.
* Not being able to understand Norwegian.
* Permanent nursing home and estimated to stay alive for less than 6 months

Where it's running

  • Drammen Hospital
    Drammen, Akershus, Norway
    Recruiting

Study contacts

Similar studies

Other studies for the same condition or treatment. Recruiting studies are listed first.

How to take part

  1. Review the eligibility criteria above with your treating physician.
  2. Check the official listing on ClinicalTrials.gov for the latest contact details and recruitment status.
  3. Contact the study coordinator or principal investigator to ask for pre-screening. Pre-screening is free and never obligates you to enroll.
Last reviewed 2026-11-14 by the Find a Trial editorial team. Information on this page is for educational purposes and is not medical advice. Always consult qualified healthcare professionals about clinical trial participation.